Ensysce Biosciences Inc (ENSC) Live Share Price, Invest From India

Ensysce Biosciences Inc Stock Performance

as on March 25, 2026 at 6:57 am IST

Day's Low
Day's High
$0.53
Day's Price Range
$0.57
$0.56
5.36%
Downside
1.79%
Upside
52 Week's Low
52 Week's High
$0.31
52-Week Price Range
$4.85
$0.56
43.86%
Downside
766.07%
Upside

Ensysce Biosciences Inc share price movements today

Previous Close: $0.59
Open: $0.57
Volume: 519.6K
Day's Low - High: $0.53 - $0.57
52 Week Low - High: $0.31 - $4.85

Ensysce Biosciences Inc Historical Returns

1 Month Return: + 47.59 %
3 Month Return: -47.28 %
1 Year Return: -83.28 %
3 Year Return: -99.4 %
5 Year Return: 0 %

Ensysce Biosciences Inc Stock Fundamentals & Key Indicators

Check Ensysce Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1M

EPS (TTM)

-4.73

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.31

Industry PE ratio

PEG Ratio

EBITDA

-24.2M

Revenue (TTM)

4.5M

Profit Margin

-244.49%

Return On Equity TTM

-294.39%

Ensysce Biosciences Inc Stock Valuation

Track how Ensysce Biosciences Inc P/E has moved over time to understand its valuation trends.

Ensysce Biosciences Inc in the last 5 years

Overview
Trends

Lowest (-178.15x)

June 30, 2022

Industry (0.00x)

March 25, 2026

Today (-0.31x)

March 25, 2026

Highest (-0.34x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.31x

Ensysce Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ensysce Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ensysce Biosciences Inc	BUY	$2.1M	NA	-0.31	-244.49%
Alnylam Pharmaceuticals, Inc.	BUY	$41.4B	126.75%	133.41	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.3B	112.49%	29.68	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.5B	58.91%	17.67	31.41%

Stock Returns calculator for Ensysce Biosciences Inc Stock including INR - Dollar returns

The Ensysce Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ensysce Biosciences Inc investment value today

Current value as on today

₹25,541

Returns

₹74,459

(-74.46%)

Returns from Ensysce Biosciences Inc Stock

₹84,000 (-84%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Ensysce Biosciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Ensysce Biosciences Inc. Average target price of $16.45

Ensysce Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Ensysce Biosciences Inc.

What analysts predicted

96.6%UPSIDE

Target Price

$16.45

Current Price

$0.56

Analyzed by

7 Analysts

Target

$16.45

Ensysce Biosciences Inc target price $16.45, a slight upside of 96.6% compared to current price of $0.56. According to 7 analysts rating.

Ensysce Biosciences Inc Stock’s Investor Sentiment and Interest

Investment in Ensysce Biosciences Inc Shares on INDmoney has grown by 467.56% over the past 30 days, indicating increased transactional activity.

Time period: February 23, 2026 to March 25, 2026

Change:467.56% versus previous 30 day period

Search interest for Ensysce Biosciences Inc Stock has increased by 671% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 23, 2026 to March 25, 2026

Change:671% versus previous 30 day period

Ensysce Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	3	1	1	1	0
Gross Profit	-1	-1	-1	0	0	1	-2	1	0	-2
Operating Income	-2	-2	-3	-1	-1	0	-3	-1	-1	-3
EBITDA	0	-2	-3	-1	-1	0	-3	-1	-1	0
Interest Expense	-	0	0	1	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-2	-3	-3	-1	0	-3	-1	-1	-3
Income Tax Expense	0	0	0	0	0	-	0	-	-	-
Net Income	-2	-2	-3	-3	-1	0	-3	-1	-1	-3
Net Profit Margin	-455.12%	-617.75%	-680.23%	-1019.23%	-1082.41%	19.36%	-273.42%	-147.42%	-126.39%	-756.26%

Ensysce Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	1	3	3	2	2	5
Gross Profit	-	-1	-3	3	3	-17	-5	-2
Operating Income	0	0	-3	-1	-19	-24	-10	-6
EBITDA	0	0	-3	0	-19	-24	-10	-6
Interest Expense	-	-	-	0	1	0	0	1
Depreciation	-	-	-	0	0	-	-	-
Income Before Tax	0	2	0	0	-29	-24	-10	-7
Income Tax Expense	0	0	0	0	0	0	0	-
Net Income	0	2	1	0	-29	-24	-10	-7
Net Profit Margin	0.00%	0.00%	83.70%	1.44%	-825.38%	-989.21%	-475.71%	-153.30%

Ensysce Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-2	-3	-3	-1	0	-3	-1	-1	-3
Operating Cash Flow	-2	-1	-3	-2	-1	0	-1	-2	-1
Investing Cash Flow	-	-	-	-	-	-	-	-	0
Financing Cash Flow	0	1	5	0	4	0	1	1	1
Change in Cash	-2	0	2	-2	3	0	0	0	0

Ensysce Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	0	0	-29	-24	-10	-7
Operating Cash Flow	-1	10	-1	-8	-17	-10	-7,502,700
Investing Cash Flow	0	0	183	-	0	-	-
Financing Cash Flow	0	-11	1	20	8	8	9,881,173
Change in Cash	0	0	0	12	-9	-2	2,378,473

Global Institutional Holdings in Ensysce Biosciences Inc

Funds	Holdings
Virtu Financial LLC	0.39%
FNY Investment Advisers, LLC	0.1%
Genworth Financial Wealth Mgmt Inc	0%
Tower Research Capital LLC	0.04%
XTX Topco Ltd	0.3%

See all

Insights on Ensysce Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Ensysce Biosciences Inc has experienced a drawdown of -99.4%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 89.2%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 99.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -1.73M → -3.72M (in $), with an average decrease of 115.1% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, ENSC stock has moved down by -7.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.37M → 493.10K (in $), with an average decrease of 64.0% per quarter

About Ensysce Biosciences Inc

ensysce biosciences, san diego, ca, is an integrated drug delivery company for both small and large molecules. to overcome the major problem of non-medical use of opioid products, ensysce is using its prodrug technology to improve abuse deterrent properties. the tap bio-md™ abuse deterrent and mpar™ overdose resistant pain platforms, with worldwide intellectual patent protection, eliminate the ability to abuse opioid products by the non-oral route. this abuse is the fastest growing drug problem in the u.s. and it leads to billions in healthcare costs annually. for additional information about ensysce biosciences please visit www.ensysce.com.

Organisation	Ensysce Biosciences Inc
Headquarters	7946 Ivanhoe Avenue, La Jolla, CA, United States, 92037
CEO	Dr. D. Lynn Kirkpatrick Ph.D.
E-voting on shares	Click here to vote

Key Management of Ensysce Biosciences Inc

Name	Title
Dr. D. Lynn Kirkpatrick Ph.D.	President, CEO & Director
Mr. David C. Humphrey CPA	CFO, Secretary & Treasurer
Mr. Geoffrey Birkett	Chief Commercial Officer
Dr. Jeffrey Millard Ph.d.	Chief Operating Officer
Dr. William K. Schmidt Ph.D.	Chairman of Clinical Advisory Board & Chief Medical Officer
Dr. Linda Pestano Ph.D.	Chief Development Officer

FAQs

What is Ensysce Biosciences Inc share price today?

Ensysce Biosciences Inc share price today is $0.56 as on March 25, 2026 at 1:27 am IST at the close of the market. Ensysce Biosciences Inc share today touched a day high of $0.57 and a low of $0.53.

What is the 52 week high and 52 week low for Ensysce Biosciences Inc share?

Ensysce Biosciences Inc share touched a 52 week high of $4.85 on April 23, 2025 and a 52 week low of $0.31 on February 18, 2026. Ensysce Biosciences Inc stock price today i.e. March 25, 2026 at 1:27 am IST is closed at $0.56,which is 88.45% down from its 52 week high and 78.12% up from its 52 week low.

What is Ensysce Biosciences Inc's market capitalisation today?

Ensysce Biosciences Inc market capitalisation is $0.00T as on March 25, 2026 at 1:27 am IST.

How to invest in Ensysce Biosciences Inc Stock (ENSC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ensysce Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ensysce Biosciences Inc Shares that will get you 2.6786 shares as per Ensysce Biosciences Inc share price of $0.56 per share as on March 25, 2026 at 1:27 am IST.

What is the minimum amount required to buy Ensysce Biosciences Inc Stock (ENSC) from India?

Indian investors can start investing in Ensysce Biosciences Inc (ENSC) shares with as little as ₹93.734 or $1 (as of March 25, 2026 at 7:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Ensysce Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on March 25, 2026 at 7:40 am IST). Based on Ensysce Biosciences Inc share’s latest price of $0.56 as on March 25, 2026 at 1:27 am IST, you will get 17.8571 shares of Ensysce Biosciences Inc. Learn more about fractional shares .